Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

ecancermedicalscience editor's choice for September 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for September 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
18 Sep 2014

Benefits of investing in skin cancer prevention

Craig Sinclair - Cancer Council Victoria, Victoria, Australia
Benefits of investing in skin cancer prevention ( Craig Sinclair - Cancer Council Victoria, Victoria, Australia )
11 Sep 2014

Skin cancer across the world and ways of preventing risk

Prof Adele Green - Deputy Director, Queensland Institute of Medical Research, Brisbane, Australia
Skin cancer across the world and ways of preventing risk ( Prof Adele Green - Deputy Director, Queensland Institute of Medical Research, Brisbane, Australia )
11 Sep 2014

Risk of common skin cancer increased by as much as 90 per cent with sunbeds, study finds

Patrick Tierney - University of Dundee, Dundee, UK
Risk of common skin cancer increased by as much as 90 per cent with sunbeds, study finds ( Patrick Tierney - University of Dundee, Dundee, UK )
11 Sep 2014

Moles on the skin increase skin cancer risk

Dr Eugene Ong - University of Oxford, Oxford, UK
Moles on the skin increase skin cancer risk ( Dr Eugene Ong - University of Oxford, Oxford, UK )
11 Sep 2014

Global prostate cancer disparities and the parts both genetic and behavioural factors play

Dr Folakemi Odedina - College of Pharmacy, University of Florida, Gainesville, USA
Global prostate cancer disparities and the parts both genetic and behavioural factors play ( Dr Folakemi Odedina - College of Pharmacy, University of Florida, Gainesville, USA )
28 Aug 2014

Benefits of metronomic chemotherapy and the aims of the Metronomic Global Health Initiative

Dr Nicolas André - Hôpital pour Enfants de La Timone, Marseille, France
Benefits of metronomic chemotherapy and the aims of the Metronomic Global Health Initiative ( Dr Nicolas André - Hôpital pour Enfants de La Timone, Marseille, France )
10 Jul 2014

Tackling inequality in access to cancer care and information

Prof Mark Lawler - Queen's University Belfast, Belfast, UK
Tackling inequality in access to cancer care and information ( Prof Mark Lawler - Queen's University Belfast, Belfast, UK )
20 Jun 2014

ecancermedicalscience Editor's Choice for May 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for May 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
20 May 2014

Rituximab versus idelalisib in refractory CLL

Prof John Gribben - Queen Mary University London, London, UK; Prof Peter Hillmen - St James’ University Hospital, Leeds, UK
Rituximab versus idelalisib in refractory CLL ( Prof John Gribben - Queen Mary University London, London, UK; Prof Peter Hillmen - St James’ University  Hospital, Leeds, UK )
9 May 2014

Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic lymphocytic leukaemia patients

Dr Valentin Goede - University of Cologne, Cologne, Germany
Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic lymphocytic leukaemia patients ( Dr Valentin Goede - University of Cologne, Cologne, Germany )
8 May 2014

History and ongoing work of AORTIC

Dr James Holland - Mount Sinai Hospital, New York, USA
History and ongoing work of AORTIC ( Dr James Holland - Mount Sinai Hospital, New York, USA )
5 May 2014